Your browser doesn't support javascript.
loading
Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning.
Morsink, L M; van Doesum, J; Choi, G; Hazenberg, C L E; Biswana, A; Meppelink, F; Bungener, L B; Lambeck, A J A; Huls, G.
Afiliação
  • Morsink LM; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands. l.m.morsink@umcg.nl.
  • van Doesum J; University of Groningen, Groningen, the Netherlands. l.m.morsink@umcg.nl.
  • Choi G; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • Hazenberg CLE; University of Groningen, Groningen, the Netherlands.
  • Biswana A; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • Meppelink F; University of Groningen, Groningen, the Netherlands.
  • Bungener LB; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • Lambeck AJA; University of Groningen, Groningen, the Netherlands.
  • Huls G; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
Blood Cancer J ; 12(1): 6, 2022 01 12.
Article em En | MEDLINE | ID: mdl-35022420

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Ciclofosfamida / Vacinas contra COVID-19 / COVID-19 / Imunossupressores Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Ciclofosfamida / Vacinas contra COVID-19 / COVID-19 / Imunossupressores Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda